From the Pan-cancer analysis using the TIMER tool, DLK2 was significantly upregulated in the tumor tissues compared with the non-tumor tissues in many cancer types, including ccRCC (Figure 2A) (*** p < 0.001). Here, DLK2 is linked to cancer.